Industry - Data Breach
Executive Summary
Healthcare AI company Tempus AI faces multiple class action lawsuits for allegedly collecting and disclosing genetic testing results without authorization, using data from Ambry Genetics Corporation to train AI models. The company reportedly shared this genetic data with over 70 pharmaceutical and biotechnology firms including AstraZeneca, Pfizer, and GlaxoSmithKline under commercial agreements. The lawsuits challenge both the use of patient genetic information for AI training and its subsequ...
What Happened
Tempus AI, a healthcare artificial intelligence company, faces multiple class action lawsuits for allegedly collecting and disclosing genetic testing results without proper authorization. The company obtained genetic data from Ambry Genetics Corporation's database and used it to train AI models. Tempus AI then shared this genetic information with over 70 pharmaceutical and biotechnology companies, including AstraZeneca, Pfizer, Bristol Myers Squibb, and GlaxoSmithKline, under commercial agreements.
Who Is Affected
Patients who underwent genetic testing through Ambry Genetics Corporation are affected, as their genetic information was allegedly used without authorization. The lawsuits indicate these individuals had their sensitive genetic data accessed by Tempus AI and subsequently shared with dozens of pharmaceutical and biotechnology firms. The geographic scope and total number of affected patients is not specified in available sources.
Why It Matters
This case highlights the growing risks of sensitive health data being repurposed for commercial AI development without explicit patient consent. Genetic information is among the most personal and immutable data types, with implications for individuals and their blood relatives. The alleged sharing of this data with over 70 companies demonstrates how patient information can be distributed far beyond the original testing context, creating privacy concerns that extend well into the future.
What You Should Do
If you have undergone genetic testing through Ambry Genetics, contact the company to determine if your data may have been included in transfers to Tempus AI and request information about your rights. Review any consent forms you signed for genetic testing to understand what data-sharing permissions you may have granted. Consider monitoring the class action lawsuits to determine if you are eligible to participate or receive notification of any settlement. Going forward, carefully review privacy policies and data-sharing practices before consenting to genetic testing services.
Summary generated from verified sources and reviewed before publication. How we summarize.